table of content
1 Introduction to Research & Analysis Reports
1.1 Self-administered Parenteral Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Self-administered Parenteral Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Self-administered Parenteral Overall Market Size
2.1 Global Self-administered Parenteral Market Size: 2023 VS 2030
2.2 Global Self-administered Parenteral Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Self-administered Parenteral Sales: 2019-2030
3 Company Landscape
3.1 Top Self-administered Parenteral Players in Global Market
3.2 Top Global Self-administered Parenteral Companies Ranked by Revenue
3.3 Global Self-administered Parenteral Revenue by Companies
3.4 Global Self-administered Parenteral Sales by Companies
3.5 Global Self-administered Parenteral Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Self-administered Parenteral Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Self-administered Parenteral Product Type
3.8 Tier 1, Tier 2 and Tier 3 Self-administered Parenteral Players in Global Market
3.8.1 List of Global Tier 1 Self-administered Parenteral Companies
3.8.2 List of Global Tier 2 and Tier 3 Self-administered Parenteral Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Self-administered Parenteral Market Size Markets, 2023 & 2030
4.1.2 Pre-filled Syringes
4.1.3 Autoinjectors
4.1.4 Pen Injectors
4.1.5 Others
4.2 By Type - Global Self-administered Parenteral Revenue & Forecasts
4.2.1 By Type - Global Self-administered Parenteral Revenue, 2019-2024
4.2.2 By Type - Global Self-administered Parenteral Revenue, 2025-2030
4.2.3 By Type - Global Self-administered Parenteral Revenue Market Share, 2019-2030
4.3 By Type - Global Self-administered Parenteral Sales & Forecasts
4.3.1 By Type - Global Self-administered Parenteral Sales, 2019-2024
4.3.2 By Type - Global Self-administered Parenteral Sales, 2025-2030
4.3.3 By Type - Global Self-administered Parenteral Sales Market Share, 2019-2030
4.4 By Type - Global Self-administered Parenteral Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Self-administered Parenteral Market Size, 2023 & 2030
5.1.2 Pharmacy
5.1.3 Online Sales
5.1.4 Other
5.2 By Application - Global Self-administered Parenteral Revenue & Forecasts
5.2.1 By Application - Global Self-administered Parenteral Revenue, 2019-2024
5.2.2 By Application - Global Self-administered Parenteral Revenue, 2025-2030
5.2.3 By Application - Global Self-administered Parenteral Revenue Market Share, 2019-2030
5.3 By Application - Global Self-administered Parenteral Sales & Forecasts
5.3.1 By Application - Global Self-administered Parenteral Sales, 2019-2024
5.3.2 By Application - Global Self-administered Parenteral Sales, 2025-2030
5.3.3 By Application - Global Self-administered Parenteral Sales Market Share, 2019-2030
5.4 By Application - Global Self-administered Parenteral Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Self-administered Parenteral Market Size, 2023 & 2030
6.2 By Region - Global Self-administered Parenteral Revenue & Forecasts
6.2.1 By Region - Global Self-administered Parenteral Revenue, 2019-2024
6.2.2 By Region - Global Self-administered Parenteral Revenue, 2025-2030
6.2.3 By Region - Global Self-administered Parenteral Revenue Market Share, 2019-2030
6.3 By Region - Global Self-administered Parenteral Sales & Forecasts
6.3.1 By Region - Global Self-administered Parenteral Sales, 2019-2024
6.3.2 By Region - Global Self-administered Parenteral Sales, 2025-2030
6.3.3 By Region - Global Self-administered Parenteral Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Self-administered Parenteral Revenue, 2019-2030
6.4.2 By Country - North America Self-administered Parenteral Sales, 2019-2030
6.4.3 US Self-administered Parenteral Market Size, 2019-2030
6.4.4 Canada Self-administered Parenteral Market Size, 2019-2030
6.4.5 Mexico Self-administered Parenteral Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Self-administered Parenteral Revenue, 2019-2030
6.5.2 By Country - Europe Self-administered Parenteral Sales, 2019-2030
6.5.3 Germany Self-administered Parenteral Market Size, 2019-2030
6.5.4 France Self-administered Parenteral Market Size, 2019-2030
6.5.5 U.K. Self-administered Parenteral Market Size, 2019-2030
6.5.6 Italy Self-administered Parenteral Market Size, 2019-2030
6.5.7 Russia Self-administered Parenteral Market Size, 2019-2030
6.5.8 Nordic Countries Self-administered Parenteral Market Size, 2019-2030
6.5.9 Benelux Self-administered Parenteral Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Self-administered Parenteral Revenue, 2019-2030
6.6.2 By Region - Asia Self-administered Parenteral Sales, 2019-2030
6.6.3 China Self-administered Parenteral Market Size, 2019-2030
6.6.4 Japan Self-administered Parenteral Market Size, 2019-2030
6.6.5 South Korea Self-administered Parenteral Market Size, 2019-2030
6.6.6 Southeast Asia Self-administered Parenteral Market Size, 2019-2030
6.6.7 India Self-administered Parenteral Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Self-administered Parenteral Revenue, 2019-2030
6.7.2 By Country - South America Self-administered Parenteral Sales, 2019-2030
6.7.3 Brazil Self-administered Parenteral Market Size, 2019-2030
6.7.4 Argentina Self-administered Parenteral Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Self-administered Parenteral Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Self-administered Parenteral Sales, 2019-2030
6.8.3 Turkey Self-administered Parenteral Market Size, 2019-2030
6.8.4 Israel Self-administered Parenteral Market Size, 2019-2030
6.8.5 Saudi Arabia Self-administered Parenteral Market Size, 2019-2030
6.8.6 UAE Self-administered Parenteral Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Becton, Dickinson and Company
7.1.1 Becton, Dickinson and Company Company Summary
7.1.2 Becton, Dickinson and Company Business Overview
7.1.3 Becton, Dickinson and Company Self-administered Parenteral Major Product Offerings
7.1.4 Becton, Dickinson and Company Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.1.5 Becton, Dickinson and Company Key News & Latest Developments
7.2 scPharmaceuticals
7.2.1 scPharmaceuticals Company Summary
7.2.2 scPharmaceuticals Business Overview
7.2.3 scPharmaceuticals Self-administered Parenteral Major Product Offerings
7.2.4 scPharmaceuticals Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.2.5 scPharmaceuticals Key News & Latest Developments
7.3 Harro Hofliger
7.3.1 Harro Hofliger Company Summary
7.3.2 Harro Hofliger Business Overview
7.3.3 Harro Hofliger Self-administered Parenteral Major Product Offerings
7.3.4 Harro Hofliger Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.3.5 Harro Hofliger Key News & Latest Developments
7.4 Owen Mumford
7.4.1 Owen Mumford Company Summary
7.4.2 Owen Mumford Business Overview
7.4.3 Owen Mumford Self-administered Parenteral Major Product Offerings
7.4.4 Owen Mumford Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.4.5 Owen Mumford Key News & Latest Developments
7.5 Haselmeier
7.5.1 Haselmeier Company Summary
7.5.2 Haselmeier Business Overview
7.5.3 Haselmeier Self-administered Parenteral Major Product Offerings
7.5.4 Haselmeier Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.5.5 Haselmeier Key News & Latest Developments
7.6 Stevanato Group
7.6.1 Stevanato Group Company Summary
7.6.2 Stevanato Group Business Overview
7.6.3 Stevanato Group Self-administered Parenteral Major Product Offerings
7.6.4 Stevanato Group Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.6.5 Stevanato Group Key News & Latest Developments
7.7 Ypsomed AG
7.7.1 Ypsomed AG Company Summary
7.7.2 Ypsomed AG Business Overview
7.7.3 Ypsomed AG Self-administered Parenteral Major Product Offerings
7.7.4 Ypsomed AG Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.7.5 Ypsomed AG Key News & Latest Developments
7.8 Solteam Group
7.8.1 Solteam Group Company Summary
7.8.2 Solteam Group Business Overview
7.8.3 Solteam Group Self-administered Parenteral Major Product Offerings
7.8.4 Solteam Group Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.8.5 Solteam Group Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Self-administered Parenteral Major Product Offerings
7.9.4 AstraZeneca Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Enable lnjections
7.10.1 Enable lnjections Company Summary
7.10.2 Enable lnjections Business Overview
7.10.3 Enable lnjections Self-administered Parenteral Major Product Offerings
7.10.4 Enable lnjections Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.10.5 Enable lnjections Key News & Latest Developments
7.11 CCBio
7.11.1 CCBio Company Summary
7.11.2 CCBio Business Overview
7.11.3 CCBio Self-administered Parenteral Major Product Offerings
7.11.4 CCBio Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.11.5 CCBio Key News & Latest Developments
7.12 Phillips-Medisize Corporation
7.12.1 Phillips-Medisize Corporation Company Summary
7.12.2 Phillips-Medisize Corporation Business Overview
7.12.3 Phillips-Medisize Corporation Self-administered Parenteral Major Product Offerings
7.12.4 Phillips-Medisize Corporation Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.12.5 Phillips-Medisize Corporation Key News & Latest Developments
7.13 Sorrel Medical
7.13.1 Sorrel Medical Company Summary
7.13.2 Sorrel Medical Business Overview
7.13.3 Sorrel Medical Self-administered Parenteral Major Product Offerings
7.13.4 Sorrel Medical Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.13.5 Sorrel Medical Key News & Latest Developments
7.14 Krontec Healthcare
7.14.1 Krontec Healthcare Company Summary
7.14.2 Krontec Healthcare Business Overview
7.14.3 Krontec Healthcare Self-administered Parenteral Major Product Offerings
7.14.4 Krontec Healthcare Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.14.5 Krontec Healthcare Key News & Latest Developments
7.15 Subcuject Aps
7.15.1 Subcuject Aps Company Summary
7.15.2 Subcuject Aps Business Overview
7.15.3 Subcuject Aps Self-administered Parenteral Major Product Offerings
7.15.4 Subcuject Aps Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.15.5 Subcuject Aps Key News & Latest Developments
7.16 Ascendia Pharmaceuticals
7.16.1 Ascendia Pharmaceuticals Company Summary
7.16.2 Ascendia Pharmaceuticals Business Overview
7.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Major Product Offerings
7.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.16.5 Ascendia Pharmaceuticals Key News & Latest Developments
7.17 West Pharmaceutical Services, Inc.
7.17.1 West Pharmaceutical Services, Inc. Company Summary
7.17.2 West Pharmaceutical Services, Inc. Business Overview
7.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Major Product Offerings
7.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.17.5 West Pharmaceutical Services, Inc. Key News & Latest Developments
8 Global Self-administered Parenteral Production Capacity, Analysis
8.1 Global Self-administered Parenteral Production Capacity, 2019-2030
8.2 Self-administered Parenteral Production Capacity of Key Manufacturers in Global Market
8.3 Global Self-administered Parenteral Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Self-administered Parenteral Supply Chain Analysis
10.1 Self-administered Parenteral Industry Value Chain
10.2 Self-administered Parenteral Upstream Market
10.3 Self-administered Parenteral Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Self-administered Parenteral Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
